143678-60-8

Basic information

• Product Name: O^ω-<(5S,R)-5-<<<(4S,5R)-4-(cyclohexylmethyl)-3-<(1,1-dimethylethoxy)carbonyl>-2,2-dimethyl-5-oxazolidinyl>carbonyl>oxy>-4-(2-methylpropyl)pentanoyl>-N^α-<(phenylmethoxy)carbonyl>-L-serine, 1,1-dimethylethyl ester
• CAS NO: 143678-60-8
• Molecular Weight: 774.993
• Mol File: 143678-60-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: O^ω-<(5S,R)-5-<<<(4S,5R)-4-(cyclohexylmethyl)-3-<(1,1-dimethylethoxy)carbonyl>-2,2-dimethyl-5-oxazolidinyl>carbonyl>oxy>-4-(2-methylpropyl)pentanoyl>-N^α-<(phenylmethoxy)carbonyl>-L-serine, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: O^ω-<(5S,R)-5-<<<(4S,5R)-4-(cyclohexylmethyl)-3-<(1,1-dimethylethoxy)carbonyl>-2,2-dimethyl-5-oxazolidinyl>carbonyl>oxy>-4-(2-methylpropyl)pentanoyl>-N^α-<(phenylmethoxy)carbonyl>-L-serine, 1,1-dimethylethyl ester(143678-60-8)
• EPA Substance Registry System: O^ω-<(5S,R)-5-<<<(4S,5R)-4-(cyclohexylmethyl)-3-<(1,1-dimethylethoxy)carbonyl>-2,2-dimethyl-5-oxazolidinyl>carbonyl>oxy>-4-(2-methylpropyl)pentanoyl>-N^α-<(phenylmethoxy)carbonyl>-L-serine, 1,1-dimethylethyl ester(143678-60-8)

Safety Data

• Hazardous Substances Data: 143678-60-8(Hazardous Substances Data)

Upstream product

• 59859-77-7 2-benzyloxycarbonylamino-3-hydroxy-propionic acid tert-butyl ester 
• 143508-58-1 (1S,R)-1-(2-methylpropyl)-5-oxo-5-hydroxypentyl (4S,5R)-4-(cyclohexylmethyl)-2,2-dimethyl-3-<(1,1-dimethylethoxy)carbonyl>-5-oxazolidinecarbxylate 

Downstream Products

• 137226-85-8 (9S,12S,13R)-12-(cyclohexylmethyl)-9--L-phenylalanyl>-13-hydroxy-2-(2-methylpropyl)-6,10,14-trioxo-1,7-dioxa-11-azacyclotetradecane 
• 137226-84-7 (9S,12S,13R)-12-(cyclohexylmethyl)-13-hydroxy-2-(2-methylpropyl)-9-<<(phenylmethoxy)carbonyl>amino>-6,10,14-trioxo-1,5-dioxa-11-azacyclotetradecane 

Relevant articles and documents

Highly Potent, Orally Active Diester Macrocyclic Human Renin Inhibitors

Replacing one amide bond in macrocyclic renin inhibitors of the general structure 1 and 2 with an ester linkage gave glutamate-derived inhibitors 3 and serine-derived inhibitors 4.While this oxygen-for-nitrogen exchange had little effect on potency in the